Morphology of acute promyelocytic leukemia with cytogenetic or molecular evidence for the diagnosis: Characterization of additional microgranular variants

American Journal of Hematology

Volumn 56, Issue 3, 1997, Pages 131-142

  Neame, Peter B ^a,b   Soamboonsrup, Praniti ^a   Leber, Brian ^b   Carter, Ronald F ^b   Sunisloe, Linda ^a   Patterson, Wendy ^a   Orzel, Andrea ^a   Bates, Shannon ^b   McBride, John A ^a,b  

^a HAMILTON HEALTH SCIENCES   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Acute promyelocytic leukemia; Cytogenetics; FISH; Immunophenotyping; Molecular genetics; Morphology; RT PCR

Indexed keywords

CD14 ANTIGEN; CD2 ANTIGEN; CD33 ANTIGEN; HLA DR ANTIGEN; MICROSOMAL AMINOPEPTIDASE; RETINOIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CHROMOSOME TRANSLOCATION 15; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC HETEROGENEITY; GRANULAR CELL; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOTTING, SOUTHERN; BONE MARROW; CELL COUNT; CHILD; CYTOPLASMIC GRANULES; DISSEMINATED INTRAVASCULAR COAGULATION; DNA, NEOPLASM; FEMALE; HISTOCYTOCHEMISTRY; HUMANS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES;

EID: 0030662234     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199711)56:3<131::AID-AJH1>3.0.CO;2-Z     Document Type: Article

References (63)

1. Bonnett JM, Catovsky D, Daniel M-T, Flandrin G, Galton DAG, Gralnick HR, Sultan C: A variant form of hypergranular promyelocytic leukaemia (M3). Br J Haematol 44:169, 1980.
2. Lo Coco F, Avvisati G, Diverion D, Biondi A, Pandolfi PP, Alcalay M, De Rossi G, Petti MC, Cantù-Rajnoldi A: Rearrangements of the RAR-α gene in acute promyelocytic leukaemia: Correlations with morphology and immunophenotype. Br J Haematol 78:494, 1991.
3. Grignani F, Fagioli M, Alcalay M, Longo L, Pandolfi PP, Donti E, Biondi A, Lo Coco F, Grignani F, Pelicci PC: Acute promyelocytic leukemia: From genetics to treatment. Blood 83:10, 1994.
4. Warrell RP, Frankel SR, Miller WH, Scheinberg DA, Itri LM, Hittelman WN, Vyas R, Andreeff M, Tafuri A, Jakubowski A, Gabrilove J, Gordon MS, Dmitrovsky E: Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 324:1385, 1991.
5. Licht JD, Chomienne C, Goy A, Chen A, Scott AA, Head DR, Michaux JL, Wu Y, DeBlasio A, Miller WH, Zelenetz AD, Willman CL, Chen Z, Chen S-J, Zelent A, Macintyre E, Veil A, Cortes J, Kantarjian H, Waxman S: Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11:17). Blood 85:1083, 1995.
6. Biondi A, Rambaldi A, Pandolfi PP, Rossi V, Giudici G, Alcalay M, Lo Coco F, Diverio D, Pogliani EM, Lanzi EM, Mandelli F, Masera G, Barbui T, Pelicci PG: Molecular monitoring of the myl/retinoic acid receptor-α fusion gene in acute promyelocytic leukemia by polymerase chain reaction. Blood 80:492, 1992.
7. Paietta E, Andersen J, Gallagher R, Bennett J, Yunis J, Cassileth P, Rowe J, Wiernik PH: The immunophenotype of acute promyelocytic leukemia (APL): An ECOG study. Leukemia 8:1108, 1994.
8. Mancini M, Nanni M, Cedrone M, Diverio D, Avvisati G, Riccioni R, De Cuia MR, Fenu S, Alimena G: Combined cytogenetic, FISH and molecular analysis in acute promyelocytic leukaemia at diagnosis and in complete remission. Br J Haematol 91:878, 1995.
9. Lafage-Pochitaloff M, Alcalay M, Brunel V, Longo L, Sainty D, Simonetti J, Birg F, Pelicci PG: Acute promyelocytic leukemia cases with nonreciprocal PML/RARα or RARα/PML fusion genes. Blood 85:1169, 1995.
10. Alcalay M, Zangrilli D, Pandolfi PP, Longo L, Mencarelli A, Giacomucci A, Rocchi M, Biondi A, Rambaldi A, Lo Coco F, Diverio D, Donti E, Grignani F, Pelicci PG: Translocation breakpoint of acute promyelocytic leukemia lies within the retinoic acid receptor α locus. Proc Natl Acad Sci USA 88:1977, 1991.
11. De Thé H, Chomienne C, Lanotte M, Degos L, Dejean A: The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus. Nature 347:558, 1990.
12. Borrow J, Goddard AD, Gibbons B, Katz F, Swirsky D, Fioretos T, Dube I, Winfield DA, Kingston J, Hagemeijer A, Rees JKH, Lister TA, Solomon E: Diagnosis of acute promyelocytic leukaemia by RT- PCR: Detection of PML-RARA and RARA-PML fusion transcripts. Br J Haematol 82:529, 1992.
13. Chen S-J, Zelent A, Tong J-H, Yu H-Q, Wang Z-Y, Derré J, Berger R, Waxman S, Chen Z: Rearranagement of the retinoic acid receptor alpha and promyelocytic leukemia zinc finger genes resulting from t(11;17) (q23;q21) in a patient with acute promyelocytic leukemia. J Clin Invest 91:2260, 1993.
14. Head DR, Behm F, Raimondi S, Carroll A, Slovak M, Magenis E, Willman C, Licht J, Scott A, Gresnik V, Downing J, Butler D, Motroni T: Genetic heterogeneity of acute myeloid leukemia (AML) with FAB AML M3 morphology. Lab Invest 72:112, 1995.
15. Redner RL, Rush EA, Faas S, Rudert WA, Corey SJ: The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin- retinoic acid receptor fusion. Blood 87:882, 1996.
16. Corey SJ, Locker J, Oliveri DR, Shekhter-Levin S, Redner RL, Penchansky L, Gollin SM: A non-classical translocation involving 17q12 (retinoic acid receptor α) in acute promyelocytic leukemia (APML) with atypical features. Leukemia 8:1350, 1994.
17. Reid A, Gould A, Brand N, Cook M, Strutt P, Li J, Licht J, Waxman S, Krumlauf R, Zelent A: Leukemia translocation gene. PLZF, is expressed with a speckled nuclear pattern in early hematopoietic progenitors. Blood 86:4544, 1995.
18. Tsai S, Bartelmez S, Heyman R, Dumm K, Evans R, Collins SJ: A mutated retinoic acid receptor & exhibiting dominant negative activity alters the lineage development of a multipotent hematopoietic cell line. Genes Dev 6:2258, 1992.
19. Tsai S, Collins SJ: A dominant retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage. Proc Natl Acad Sci USA 90:7153, 1993.
20. Weis K, Rambaud S, Lavau C, Jansen J, Carvalho T, Carmo-Fonseca M, Lamond A, Dejean A: Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cells. Cell 76:345, 1994.
21. McKenna RW, Parkin J, Bloomfield CD, Sundberg RD, Brunning RD: Acute promyelocytic leukaemia: A study of 39 cases with identification of a hyperbasophilic microgranular variant. Br J Haematol 50:201, 1982.
22. Zelent A: Translocation of the RARα locus to the PML or PLZF gene in acute promyelocytic leukaemia. Br J Haematol 86:451, 1994.
23. Warrell RP, De Thé H, Wang Z-Y, Degos L: Acute promyelocytic leukemia. N Engl J Med 329:177, 1993.
24. Kanamaru A, Takemoto Y, Tanimoto M, Murakami H, Asou N, Kobayashi T, Kuriyama K, Ohmoto E, Sakamaki H, Tsubaki K, Hiraoka A, Yamada O, Oh H, Saito K, Matsuda S, Minato K, Ueda T, Ohno R: All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Blood 85:1202, 1995.
25. Dyck JA, Warrell RP, Evans RM, Miller WH: Rapid diagnosis of acute promyelocytic leukemia by immunohistochemical localization of PML/RAR-α protein. Blood 86:862, 1995.
26. Fenaux P, Le Deley MC, Castaigne S, Archimbaud E, Chomienne C, Link H, Guerci A, Duarte M, Daniel MT, Bowen D, Huebner G, Bauters F, Fegueux N, Fey M, Sanz M, Lowenberg B, Maloisel F, Auzanneau G, Sadoun A, Gardin C, Bastion Y, Ganser A, Jacky E, Dombret H, Chastang C, Degos L: Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multi-center randomized trial. Blood 82:3241, 1993.
27. Tallman MS, Andersen J, Schiffer CA, Appelbaum FR, Feusner JE, Woods WG, Ogden A, Weinstein H, Shepherd L, Rowe JM, Wiernik PH: Phase III randomized study of ALL-trans retinoic acid (ATRA) vs daunorubicin (D) and cytosine arabinoside (A) as induction therapy and ATRA vs observation as maintenance therapy for patients with previously untreated acute promyelocytic leukemia (APL). Blood [Suppl] 86:125, 1995.
28. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C: Proposals for the classification of acute leukaemias. Br J Haematol 33:451, 1976.
29. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C: Proposed revised criteria for the classification of acute mveloid leukaemia. Ann Intern Med 103:620, 1985.
30. Castoldi GL, Liso V, Specchia G, Tomasi P: Acute promyelocytic leukemia: Morphological aspects. Leukemia 8[Suppl]:27, 1994.
31. Neame PB, Soamboonsrup P, Carter R, Sunisloe LL, Bates S, Patterson W, Orzel A, McBride JA: The morphology of acute leukemia with 15;17 translocation: Further variants of APL. Implications in regard to early ATRA therapy. Blood [Suppl] 86:773, 1995.
32. Southern EM: Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98:503, 1975.
33. Feinberg AP, Yogelstein B: A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6, 1983.
34. Biondi A, Rambaldi A, Alcalay M, Pandolfi PP, Lo Coco F, Diverio D, Rossi V, Mencarelli A, Longo L, Zangrilli D, Masera G, Barbui T, Mandelli F, Grignani F, Pelicci PG: RAR-α gene rearrangements as a genetic marker for diagnosis and monitoring in acute promyelocytic leukemia. Blood 77:1418, 1991.
35. Gallagher RE, Li YP, Rao S, Paietta E, Anderson J, Etkind P, Bennett JM, Tallman MS, Weirnik PH: A characterization of acute promyelocytic leukemia cases with PML-RARα break/fusion sites in PML exon 6: Identification of a subgroup with decreased in vitro responsiveness to all-trans retinoic acid. Blood 86:1540, 1995.
36. International Committee for Standardization in Haematology: Recommended methods for cytological procedures in haematology. Clin Lab Haematol 7:55, 1985.
37. Sheehan HL, Storey GW: An improved method of staining leucocyte granules with Sudan black B. J Pathol Bacteriol 40:336, 1947.
38. Li CY, Lam KW, Yam LT: Esterases in human leukocytes. J Histochem Cytochem 21:1, 1973.
39. Wang JCY, Beauregard P, Soamboonsrup P, Neame PB: Monoclonal antibodies in the management of acute leukemia. Am J Hematol 50:188, 1995.
40. Neame PB, Soamboonsrup P, Quigley JG, Pewarchuck W: The use of monoclonal antibodies and immune markers in the diagnosis, prognosis, and therapy of acute leukemia. Transfus Med Rev 8:59, 1994.
41. Vyas RC, Frankel SR, Agbor P, Miller WH, Warrell RP, Hittelman WN: Probing the pathobiology of response to ALL-trans retinoic acid in acute promyelocytic leukemia: Premature chromosome condensation/fluorescence in situ hybridization analysis. Blood 87:218, 1996.
42. Edwards RH, Wasik MA, Kamoun M, Finan J, Nowell PC, Salhany KE: Immunophenotypic analysis of acute promyelocytic leukemia: Evidence for myeloid progenitor cell origin. Lab Invest 74:111, 1996.
43. Wells RA, Hummel JL, DeKoven A, Zipursky A, Kirby M, Dube I, Kamel-Reid S: A new variant translocation in acute promyelocytic leukemia: Molecular characterization and clinical correlation. Leukemia 10:735, 1996.
44. Griffin JD, Davis R, Nelson DA, Davey FR, Mayer RJ, Schiffer C, McIntyre OR, Bloomfield CD: Use of surface marker analysis to predict outcome of adult acute myeloblastic leukemia. Blood 68:1232, 1996.
45. Neame PB, Soamboonsrup P, Browman GP, Meyer RM, Benger A, Wilson WEC, Walker IR, Saeed N, McBride JA: Classifying acute leukemia by immunophenotyping: A combined FAB-immunologic classification of AML. Blood 68:1355, 1986.
46. Rovelli A, Biondi A, Cantù-Rajnoldi A, Conter V, Giudici G, Jankovic M, Lacasciulli A, Rizzari C, Romitti L, Rossi MR, Schiro R, Tosi S, Uderzo C, Masera G: Microgranular variant of acute promyelocytic leukemia in children. J Clin Oncol 10:1413, 1992.
47. Biondi A, Luciano A, Bassan R, Mininni D, Specchia G, Lanzi E, Castagna S, Cantù-Rajnoldi A, Liso V, Masera G, Barbui T, Rambaldi A: CD2 expression in acute promyelocytic leukemia is associated with microgranular morphology (FAB M3v) but not with any PML gene breakpoint. Leukemia 9:1461, 1995.
48. Scott AA, Head DR, Kopecky KJ, Appelbaum FR, Theil KS, Grever MR, Chen I-M, Whittaker MH, Griffith BB, Licht JD, Waxman S, Whalen MM, Bankhurst AD, Richter LC, Grogan TM, Willman CL: HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: A previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3. Blood 84:244, 1994.
49. Perego RA, Marenco P, Blanchi C, Cairoli R, Urbano M, Nosari AM, Muti G, Morra E, Del Monte U: PML/RARα transcripts monitored by polymerase chain reaction in acute promyelocytic leukemia during complete remission, relapse and after bone marrow transplantation. Leukemia 10:207, 1996.
50. Rowley JD, Golomb HM, Dougheriy C: 15/17 translocation, a consistent chromosomal change in acute promyelocytic leukaemia. Lancet 1:549, 1977.
51. Raelson JV, Nervi C, Rosenauer A, Benedetti L, Monczak Y, Pearson M, Pelicci PG, Miller WH Jr: The PML/RARα oncoprotein is a direct molecular target of retinoic acid in acute promyelocytic leukemia cells. Blood 88:2826, 1996.
52. Bassan R, Battista R, Viero P, d'Emilio A, Buelli M, Montaldi A, Rambaldi A, Tremul L, Dini E, Barhui T: Short-term treatment for adult hypergranular and microgranular acute promyelocytic leukemia. Leukemia 9:238, 1995.
53. Davey FR, Davis RB, MacCallum JM, Nelson DA, Mayer RJ, Ball ED, Griffin JD, Schiffer CA, Bloomfield CD: Morphologic and cytochemical characteristics of acute promyelocytic leukemia. Am J Hematol 30:221, 1989.
54. Sultan C, Heilmann-Goualt M, Tulliez M: Relationship between blast- cell morphology and occurrence of a syndrome of disseminated intravascular coagulation. Br J Haematol 24:255, 1973.
55. Head DR. Personal communication 1996.
56. Appelbaum FR, Downing J, Willman C: The biology and therapy of acute myelogenous leukemia. Education program, American Society of Hematology, Seattle, Washington, December 2-5, 1995, p 28.
57. De Rossi G, Avvisati G, Coluzzi S, Fenu S, Lo Coco F, Lopez M, Nanni M, Pasqualett D, Mandelli F: Immunological definition of acute promyelocylic leukemia (FAB M3): A study of 39 cases. Eur J Haemalol 45:168, 1990.
58. Hussey CE, Lay M, Wittwer CT, Segal GH: A simple rapid PCR- based approach for the molecular detection of t(15;17) in acute pro- myelocytic leukemia (APL). Lab Invest 74:114, 1996.
59. Golomb HM, Rowley JD, Vardiman JW, Testa JR, Butler A: "Microgranular" acute promyelocytic leukemia: A distinct clinical, ultra- structural and cytogenetic entity. Blood 55:253, 1980.
60. Ademokun AJ, Irving JAE, Maung ZT, Howard MR, Proctor SJ, Jackson GH: Basophilia. t(15;17) translocation and atypical AML. Leukemia 9:225, 1995.
61. Tallman MS, Hakimian D, Snower D, Rubin CM, Reisel H, Variakojis D: Basophilic differentiation in acute promyelocytic leukemia. Leukemia 7:521, 1993.
62. Kubonishi I, Fujishita M, Niiya K, Tajuichi H, Ohtsuki Y, Miyoshi I: Basophilic differentiation in acute promyelocytic leukemia. Acta Haematol Jpn 48:1390, 1985.
63. Yu R-Q, Huang W, Chen S-J, Jiang S-D, Chen Z: A case of acute eosinophilic granulocytic leukemia with PML-RAR alpha fusion gene expression and response to all-trans retinoic acid. Leukemia 11:609, 1997.